Welcome to LookChem.com Sign In|Join Free

CAS

  • or

441064-74-0

Post Buying Request

441064-74-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

441064-74-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 441064-74-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,1,0,6 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 441064-74:
(8*4)+(7*4)+(6*1)+(5*0)+(4*6)+(3*4)+(2*7)+(1*4)=120
120 % 10 = 0
So 441064-74-0 is a valid CAS Registry Number.

441064-74-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(7-benzyl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl)morpholine

1.2 Other means of identification

Product number -
Other names 7-benzyl-4-morpholin-4-yl-5,6,7,8-tetrahydro-pyrido[3,4-d]pyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:441064-74-0 SDS

441064-74-0Downstream Products

441064-74-0Relevant articles and documents

Process development and scale-up of a selective α1- adrenoceptor antagonist

Connolly, Terrence J.,Matchett, Michael,Sarma, Keshab

, p. 80 - 87 (2012/12/24)

A synthetic route to a potent and selective α-1-adrenergic receptor antagonist has been developed and demonstrated in a pilot plant. The route has been used in two pilot plant campaigns and has produced RO3203546 in 2.3 and 12.0 kg batch sizes. The first pilot plant campaign focused primarily on the end-game of the process with particular emphasis on the development of a method to isolate the active pharmaceutical ingredient (API). The second pilot plant campaign allowed front-end process improvements to be demonstrated. The reiterative process improvements resulted in an economical process with improved throughput and product quality when compared to the original discovery synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 441064-74-0